12/16/2024
3:26 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
7:14 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
7:05 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2024
3:26 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
2:05 PM | Cormorant Asset Management, LP (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G | |
11/01/2024
6:00 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G | |
09/24/2024
4:26 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
5:46 PM | TScan Therapeutics (Issuer)
ZDRAVESKI ZORAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
5:57 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:50 PM | TScan Therapeutics (Subject)
ZDRAVESKI ZORAN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
3:20 PM | Nicholson Garry A (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:20 PM | Gruia Gabriela (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:20 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:20 PM | Dorton Katina (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:20 PM | TScan Therapeutics (Issuer)
Woods Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024
3:05 PM | Louis Chrystal (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:17 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:25 PM | BAKER BROS. ADVISORS LP (Filed by)
TScan Therapeutics (Subject)
| Form SC 13D/A | |
04/23/2024
3:15 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
8:58 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
04/17/2024
5:25 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
5:20 AM | TScan Therapeutics (Subject)
| Form FWP | |
04/16/2024
4:21 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
04/16/2024
3:16 PM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2024
11:15 PM | TScan Therapeutics (Filer)
| Form EFFECT | |
04/10/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 10-K/A | |
04/08/2024
7:17 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:45 PM | K2 HealthVentures Equity Trust LLC (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
5:02 AM | Pitango HealthTech Fund I, L.P. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/07/2024
6:45 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/02/2024
3:21 PM | Amello Jason (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The #1 Crypto for AI (Ad) We’ve issued an urgent landmark trade alert for a new crypto wonder.
So, I decided to give you this heads-up before it’s too late.
It’s urgent because it’s what we consider “The #1 Crypto for the AI World.” Learn more about it by watching THIS NOW. |
12/21/2023
4:00 PM | BARBERICH TIMOTHY J (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
5:01 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free TCRX Stock Alerts